Literature DB >> 22700721

Single-stranded DNA oligonucleotides inhibit TLR3-mediated responses in human monocyte-derived dendritic cells and in vivo in cynomolgus macaques.

Annette E Sköld1, Maroof Hasan, Leonardo Vargas, Hela Saidi, Nathalie Bosquet, Roger Le Grand, C I Edvard Smith, Anna-Lena Spetz.   

Abstract

TLR3 is a key receptor for recognition of double-stranded RNA and initiation of immune responses against viral infections. However, hyperactive responses can have adverse effects, such as virus-induced asthma. Strategies to prevent TLR3-mediated pathology are therefore desired. We investigated the effect of single-stranded DNA oligonucleotides (ssDNA-ODNs) on TLR3 activation. Human monocyte-derived dendritic cells up-regulate maturation markers and secrete proinflammatory cytokines on treatment with the synthetic TLR3 ligand polyinosine-polycytidylic acid (poly I:C). These events were inhibited in cultures with ssDNA-ODNs. Poly I:C activation of nonhematopoietic cells was also inhibited by ssDNA-ODNs. The uptake of poly I:C into cells was reduced in the presence of ssDNA-ODNs, preventing TLR3 engagement from occurring. To confirm this inhibition in vivo, we administered ssDNA-ODNs and poly I:C, alone or in combination, via the intranasal route in cynomolgus macaques. Proinflammatory cytokines were detected in nasal secretions in the poly I:C group, while the levels were reduced in the groups receiving ssDNA-ODNs or both substances. Our results demonstrate that TLR3-triggered immune activation can be modulated by ssDNA-ODNs and provide evidence of dampening proinflammatory cytokine release in the airways of cynomolgus macaques. These findings may open novel perspectives for clinical strategies to prevent or treat inflammatory conditions exacerbated by TLR3 signaling.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22700721     DOI: 10.1182/blood-2011-12-397778

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  Novel drugs targeting Toll-like receptors for antiviral therapy.

Authors:  Mira C Patel; Kari Ann Shirey; Lioubov M Pletneva; Marina S Boukhvalova; Alfredo Garzino-Demo; Stefanie N Vogel; Jorge Cg Blanco
Journal:  Future Virol       Date:  2014-09       Impact factor: 1.831

2.  A cell-based microarray to investigate combinatorial effects of microparticle-encapsulated adjuvants on dendritic cell activation.

Authors:  Abhinav P Acharya; Matthew R Carstens; Jamal S Lewis; Natalia Dolgova; C Q Xia; Michael J Clare-Salzler; Benjamin G Keselowsky
Journal:  J Mater Chem B       Date:  2015-09-30       Impact factor: 6.331

Review 3.  Oligonucleotide Therapies: The Past and the Present.

Authors:  Karin E Lundin; Olof Gissberg; C I Edvard Smith
Journal:  Hum Gene Ther       Date:  2015-08-03       Impact factor: 5.695

4.  Human blood myeloid and plasmacytoid dendritic cells cross activate each other and synergize in inducing NK cell cytotoxicity.

Authors:  Jasper J P van Beek; Mark A J Gorris; Annette E Sköld; Ibrahim Hatipoglu; Heleen H Van Acker; Evelien L Smits; I Jolanda M de Vries; Ghaith Bakdash
Journal:  Oncoimmunology       Date:  2016-09-02       Impact factor: 8.110

5.  Protamine-stabilized RNA as an ex vivo stimulant of primary human dendritic cell subsets.

Authors:  Annette E Sköld; Jasper J P van Beek; Simone P Sittig; Ghaith Bakdash; Jurjen Tel; Gerty Schreibelt; I Jolanda M de Vries
Journal:  Cancer Immunol Immunother       Date:  2015-08-15       Impact factor: 6.968

6.  A Single-Stranded Oligonucleotide Inhibits Toll-Like Receptor 3 Activation and Reduces Influenza A (H1N1) Infection.

Authors:  Candice Poux; Aleksandra Dondalska; Joseph Bergenstråhle; Sandra Pålsson; Vanessa Contreras; Claudia Arasa; Peter Järver; Jan Albert; David C Busse; Roger LeGrand; Joakim Lundeberg; John S Tregoning; Anna-Lena Spetz
Journal:  Front Immunol       Date:  2019-09-12       Impact factor: 7.561

Review 7.  Targeting toll-like receptors: promising therapeutic strategies for the management of sepsis-associated pathology and infectious diseases.

Authors:  Athina Savva; Thierry Roger
Journal:  Front Immunol       Date:  2013-11-18       Impact factor: 7.561

8.  Rational design of antisense oligonucleotides modulating the activity of TLR7/8 agonists.

Authors:  Arwaf S Alharbi; Aurélie J Garcin; Kim A Lennox; Solène Pradeloux; Christophe Wong; Sarah Straub; Roxane Valentin; Geneviève Pépin; Hong-Mei Li; Marcel F Nold; Claudia A Nold-Petry; Mark A Behlke; Michael P Gantier
Journal:  Nucleic Acids Res       Date:  2020-07-27       Impact factor: 16.971

9.  Naturally produced type I IFNs enhance human myeloid dendritic cell maturation and IL-12p70 production and mediate elevated effector functions in innate and adaptive immune cells.

Authors:  Annette E Sköld; Till S M Mathan; Jasper J P van Beek; Georgina Flórez-Grau; Michelle D van den Beukel; Simone P Sittig; Florian Wimmers; Ghaith Bakdash; Gerty Schreibelt; I Jolanda M de Vries
Journal:  Cancer Immunol Immunother       Date:  2018-07-13       Impact factor: 6.968

10.  Single-Stranded Nucleic Acids Regulate TLR3/4/7 Activation through Interference with Clathrin-Mediated Endocytosis.

Authors:  Peter Järver; Aleksandra Dondalska; Candice Poux; AnnSofi Sandberg; Joseph Bergenstråhle; Annette E Sköld; Nathalie Dereuddre-Bosquet; Fréderic Martinon; Sandra Pålsson; Eman Zaghloul; David Brodin; Birgitta Sander; Kim A Lennox; Mark A Behlke; Samir El-Andaloussi; Janne Lehtiö; Joakim Lundeberg; Roger LeGrand; Anna-Lena Spetz
Journal:  Sci Rep       Date:  2018-10-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.